Peak Pharmacy: Through the 20th Anniversary, Witness Growth with Growth
Release time:
2021-03-22
It was the morning of 2001 # April 20 . On Shuangxi West Road in the city, banners and flowers were displayed at the gate of a pharmacy. Du Zihong, the leader of Jinhua City and the old chairman of the peak, unveiled the chain of pharmacies and announced the official opening of the peak pharmacy chain Co., Ltd. With a flick of a finger, the peak pharmacy has accompanied Jinhua people through 20 years. After counting the past steps and looking forward to the future scenery, the peak pharmacy and its employees grew up together, reorganized their clothes and set off again.
Peak Pharmacy was formerly the 17 pharmacy in the retail department of Jinhua Pharmaceutical Company. It is a public institution without operating pressure and is not sensitive to the market. Development plans such as store layout are also relatively lacking. In 2001 , after Jianfeng Group established Jianfeng Pharmaceutical and acquired Jinhua Pharmaceutical Company, in order to comply with policy requirements and market-oriented reforms, and as Jianfeng Group's further development in the pharmaceutical field, 17 retail stores were independent from pharmaceutical companies and set up chain companies, renamed Jianfeng Pharmacy. Since then, it has become an independent legal person and a market-oriented centralized enterprise with unified business objectives. Around this goal, Jianfeng Pharmacy has continuously improved its internal management, system construction, and image shaping, forming a joint force, completing the transformation of a new type of modern chain enterprise, and becoming a veteran cement enterprise, Jianfeng, in Jinhua, the base area, directly dealing with the common people. An eye-catching image window.
The transformation from a big pot of rice to a modern enterprise that is responsible for its own profits and losses cannot be successful by decorating the store and changing the management mode. As soon as the big pharmacy came up, it encountered a big problem - brand image problem. The old cement brand of Jianfeng has suddenly become a street drug seller. This change spans a lot, and many people can't react for a while. When opening the business and making panax notoginseng powder on the spot, the regular customer also joked: "don't mix cement powder with me. "
In order to quickly eliminate misunderstandings, let people change their ideas, and at the same time expand the influence of the brand, Jianfeng Pharmacy has established a new image through a series of measures: invite Shanghai experts to use the most advanced instruments for free consultation, hire famous doctors to sit in the hall, free testing, charity drugs, go deep into the street community to promote medical knowledge, organize primary school students' medical knowledge summer camp ... more means "makeover " , peak pharmacy helps peak brand to break the old impression in the hearts of the people, refresh the concept of Jinhua citizens; it also inherits and carries forward the tradition of paying attention to quality of peak brands, and establishes a reliable brand image that pays attention to drug quality and curative effect.
At the same time, Peak Pharmacy is also exploring how to better serve its customers, striving to pursue "people have nothing, people have advantages " . Other drugstores can't do it, we're going to do it. Some varieties of drugs, even if they don't make money, have to be stocked to meet the needs of customers. In order to inherit and carry forward the heritage of Renshou Hall, Tianfu Hall and other century-old stores, special stores are opened. With excellent service consciousness and service quality, the peak pharmacy has formed its own high stickiness customer base.
20 years of cold and summer, peak pharmacy step by step, through their own efforts to develop, business performance from millions to tens of millions gradually increased, and even hundreds of millions; The number of stores has increased from a dozen newly established to dozens now. It is the first batch of drug dealers certified by GSP and the first batch of designated retail pharmacies of medical insurance in Jinhua City; the number of fixed-point retail pharmacies for chronic diseases is the largest among pharmaceutical retail chain enterprises in Jinhua City.
In recent years, with the continuous deepening of the reform of my country's medical system and drug circulation system, the pharmaceutical retail industry has been greatly affected, and the sales profit of essential drugs has decreased. "Zero Price Difference " The price advantage of pharmacies over medical institutions no longer exists, and communities and township hospitals have separated part of the market, which makes the industry more competitive.
Facing the opportunities and challenges coexisting in changes, Jianfeng Pharmacy actively complies with policy changes, strives for various designated pharmacy qualifications, strengthens staff training, provides customers with professional and personalized medication guidance, and creates distinctive Pharmaceutical services to improve their core competitiveness. I have also been looking for and trying new sales models and future development directions. As early as 2014 , I cooperated with e-commerce platforms to explore online drug sales. Last year, I cooperated with take-out platforms to explore the combination of offline and online retail.
Peak Pharmacy's firm confidence comes from a group of employees who grew up with the enterprise in the past 20 years. In the face of staff training has never stopped, including pharmaceutical expertise, service etiquette, sales skills, on-site simulation and other forms. Even during the COVID-19 pandemic, employees were organized to learn remotely through online classrooms. Many senior managers start from shop assistants and make common progress with enterprises.
Various awards have proved the efforts and progress of employees. The large pharmacy team has repeatedly ranked first in the province's national pharmacy skills competitions and competitions. In the2014 National Pharmacy Combined Medication Skills Competition, he won the top five in Zhejiang Division, 2020 , "Tianqing Cup " The 4th Knowledge and Care Skills Competition Zhejiang Regional Competition won the Best Service Team Award ... The award is certainly gratifying, but what makes them more happy is to see the pennants and thank-you letters sent by customers again and again. At the beginning of 2020
, the new crown epidemic seriously affected people's lives. In the face of the outbreak of the outbreak brought about by the surge in demand for masks, alcohol, disinfectants and other materials, peak pharmacy staff Spring Festival, in the logistics almost paralyzed, serious shortage of production capacity in the case of full search for sources of goods, adhere to the front line, try to meet customer needs. And adhere to the parity sales, for the stability of the market, stable people have made a positive contribution. After the situation eased, Jianfeng Pharmacy participated in the public welfare activities of guarding angels in white, and sent gifts to the medical staff in Hubei to express respect and gratitude, reflecting the social responsibility and responsibility of an enterprise.20
has a long way to go, and20 has passed in a blink of an eye. Looking back on history and looking forward to the future, General Manager Xiang Shunjiao said: Peak Pharmacy carries the historical heritage of a century-old store and surrounds the grand goal of a century-old peak. It will continue to move forward in Do not forget your initiative mind. (Reporter
Chen Shengmu)
More information
Two Cement Enterprises Prosperous Production and Sales in May
With the gradual easing of the new crown epidemic, all over the project has started, Hubei, Yunnan two provinces cement market continued to improve, Daye peak cement company, Yunnan peak cement company two enterprises have recently shown a good momentum of production and sales. In May, the sales volume of Yunnan Jianfeng cement continued to rise. As of the time of publication, the average daily shipment volume reached more than 7400 tons, and the highest daily shipment volume reached more than 8700 tons, and the production capacity was fully released. Over the past few days, Yunnan Peak Packaging System has made great efforts to overcome the impact of narrow distribution sites and many cement varieties to ensure the completion of delivery tasks with good quality and quantity every day. In order to further balance production and sales and create conditions for the homogenization of cement delivered from the factory, Yunnan peak packaging system puts forward work requirements for relevant posts, emphasizes equipment inspection and process inspection during production, strictly implements safety operation procedures, and maintains safe and efficient operation of the system. Due to the impact of the new crown epidemic, Hubei cement market started late, Wuhan market is the hardest hit area, the current project construction is still not fully started, the volume pressure is greater. For this reason, daye peak departments cooperate closely, increase market development efforts, develop new mixing stations, focus on increasing the bulk share of Xianning, Huanggang and Wuhan markets, seize the opportunity of fine weather, and achieve the goal of rapid output. Internally, on the basis of equipment technical renovation and production capacity improvement, the delivery is effectively guaranteed, and the daily delivery capacity can basically be maintained at 10,000 tons. In May, Daye Peak sold more than 300000 tons of cement, an increase of 20% over the same period last year, with an average daily sales volume of more than 9900 tons, the highest in the current period since Daye Peak was put into production.
2020
07-31
The company's "safe production month" activities are about to start
June 2020 is the 19th national "safe production month", the theme of the activity is "eliminating hidden dangers of accidents and building a strong line of defense". A few days ago, the group company issued a notice to arrange the activities related to the organization of "safe production month" and put forward requirements. According to the group's "safe production month" activity plan, different key thematic activities will be held in the four weeks of June. The first week is the "Publicity and Safety Education Week", which focuses on the use of WeChat groups, electronic screens, publicity boards, banners, slogans and other forms for safety publicity, and organizes the study of national safety regulations, company safety system specifications and accident-free factory creation standards, Organize to watch safety warning education films, learn accident cases, etc., and improve employees' safety awareness by creating a safety atmosphere and organizing learning activities. The focus of the activities in the second week is "looking for potential sources of danger around you". Each unit takes departments and teams as units to investigate and analyze the potential risk factors in the process of daily production, maintenance and operation, find out the hazard sources that have not been included in the scope of risk point control, and report to the safety management department of the unit to form a risk assessment report, put forward solutions or suggestions, and supervise the implementation of rectification and timely eliminate potential safety hazards. The third week is the "on-site safety innovation achievements exhibition week", which focuses on the achievements of each unit in on-site safety management and on-site safety facilities in the past year, which are displayed in the form of pictures and texts through beautiful articles and wechat, so as to learn from each other and promote common progress. The fourth week is the "safety training and drill week", and the group company organizes the standardization of safety production and the elimination of hidden dangers.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-30
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-22
On April 24, Jiang Xiaomeng, chairman of the group company, presided over the 14th meeting of the 10th board of directors of the company, and deliberated and passed 14 related reports and motions such as the 2019 annual board of directors report, the 2019 general manager business report and the 2019 annual report. The general manager's report pointed out that 2019 is the first year of the implementation of the group's new five-year strategic development plan (2019-2023) and the new three-year business plan (2019-2021) for each business sector. the management team has carried out various operation and management work in an orderly manner around the general policy of "innovation and reform, integration and promotion, scientific layout and steady development", and has better completed the business objectives set by the board of directors at the beginning of the year. In the whole year, the company achieved a total operating income of 3.548 billion billion yuan, an increase of 5.51 percent over the same period last year; net profit attributable to shareholders was 0.725 billion billion yuan, with earnings per share reaching 2.11 billion yuan, an increase of 23.14 percent over the same period last year, a record high; total assets at the end of the year were 5.475 billion billion yuan, an increase of 11.71 percent over the same period last year; and net assets attributable to shareholders were 3.789 billion billion yuan, an increase of 19.81 percent. During the reporting period, the company's two main businesses have achieved great development, benefiting from the further promotion of supply-side structural reform, the overall operation of the cement industry in 2019 is stable, and the industry benefits are further improved. During the reporting period, the company made new progress in the construction of cement projects, completed the acquisition, capital increase and name change of Guizhou Mingchuan (Guizhou Huangping Jianfeng Cement Co., Ltd.), and continued to invest in the construction of its new dry cement production line with a daily output of 4500 tons of clinker.
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page